Geron
GERN
#6280
Rank
โ‚ฌ0.71 B
Marketcap
1,13ย โ‚ฌ
Share price
3.15%
Change (1 day)
-70.07%
Change (1 year)

Revenue for Geron (GERN)

Revenue in 2025 (TTM): โ‚ฌ0.16 Billion

According to Geron's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.15 Billion. In 2024 the company made a revenue of โ‚ฌ73.98 Million an increase over the revenue in the year 2023 that were of โ‚ฌ0.21 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Geron from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.16 B121.83%
2024 โ‚ฌ73.98 M34411.34%
2023 โ‚ฌ0.21 M-61.41%
2022 โ‚ฌ0.55 M-54.83%
2021 โ‚ฌ1.23 M497.99%
2020 โ‚ฌ0.2 M-49.91%
2019 โ‚ฌ0.41 M-55.93%
2018 โ‚ฌ0.93 M4.98%
2017 โ‚ฌ0.88 M-84.85%
2016 โ‚ฌ5.85 M-82.39%
2015 โ‚ฌ33.26 M3408.77%
2014 โ‚ฌ0.94 M2.04%
2013 โ‚ฌ0.92 M-54.64%
2012 โ‚ฌ2.04 M9.09%
2011 โ‚ฌ1.87 M-29.92%
2010 โ‚ฌ2.67 M122.35%
2009 โ‚ฌ1.2 M-39.91%
2008 โ‚ฌ2 M-61.59%
2007 โ‚ฌ5.22 M110.19%
2006 โ‚ฌ2.48 M914.47%
2005 โ‚ฌ0.24 M
2003 โ‚ฌ0.75 M-30.77%
2002 โ‚ฌ1.08 M-73.46%
2001 โ‚ฌ4.09 M-41.57%
2000 โ‚ฌ7.01 M29.63%
1999 โ‚ฌ5.41 M-5.55%
1998 โ‚ฌ5.73 M-6.85%
1997 โ‚ฌ6.15 M37.74%
1996 โ‚ฌ4.46 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ0 M-100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ24.98 B 15,759.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚ฌ1.04 B 563.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
โ‚ฌ4.13 B 2,524.33%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
โ‚ฌ65.07 M-58.69%๐Ÿ‡บ๐Ÿ‡ธ USA